Nanogrow

Nanogrow is a biotechnology company developing an end-to-end nanobody bioengineering platform and next-generation biologic therapies for human and veterinary health. Its single-domain antibody technology is designed for high-affinity targeting and localized delivery, with a focus on dermatological and inflammatory conditions such as psoriasis and atopic dermatitis, as well as oncology. The company engineers and develops therapeutic candidates and works with pharmaceutical partners to advance them toward clinical use.